Premium
VYNE Therapeutics Inc (VYNE)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its most advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate... VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its most advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.09 | 5.05617977528 | 1.78 | 1.9298 | 1.75 | 99924 | 1.81717726 | CS |
| 4 | 0.14 | 8.09248554913 | 1.73 | 1.95 | 1.44 | 179026 | 1.67338651 | CS |
| 12 | -0.89 | -32.2463768116 | 2.76 | 2.94 | 1.44 | 126985 | 1.92286391 | CS |
| 26 | -0.4707 | -20.1093689922 | 2.3407 | 4.29 | 1.44 | 122181 | 2.46518997 | CS |
| 52 | -0.37 | -16.5178571429 | 2.24 | 4.29 | 1.44 | 85911 | 2.35767795 | CS |
| 156 | -6.41 | -77.4154589372 | 8.28 | 9.9 | 1.44 | 298734 | 4.43373057 | CS |
| 260 | -104.69 | -98.2451201201 | 106.56 | 237.6 | 1.44 | 1006568 | 94.31002039 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
